SPI1 and Alzheimer disease: In a study combining snRNA-seq with snATAC-seq in the same tissue, it was found that two microglial subpopulations more present in the prefrontal cortex of late-stage AD patients had more open binding sites for the transcription factor SPI1 but lower expression of its candidate target genes (Morabito et al., 2021).